Risk of lung disease in PI MZ heterozygotes: Current status and future research directions

Annals of the American Thoracic Society

Volumn 13, Issue , 2016, Pages S341-S345

  Silverman, Edwin K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alpha 1 antitrypsin deficiency; Association analysis; Chronic obstructive pulmonary disease; Genetics; Heterozygote risk

Indexed keywords

MACROPHAGE ELASTASE; NICOTINIC RECEPTOR; SERINE PROTEINASE INHIBITOR; ALPHA 1 ANTITRYPSIN; SERPINA1 PROTEIN, HUMAN;

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC RISK; GENOTYPE ENVIRONMENT INTERACTION; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HUMAN; LUNG DISEASE; LUNG EMPHYSEMA; MEDICAL RESEARCH; RISK ASSESSMENT; SERPINA1 GENE; SPIROMETRY; ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; COMPLICATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HOMOZYGOTE; PHENOTYPE;

ALLELES; ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84989879553     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201507-437KV     Document Type: Conference Paper

References (29)

1. Laurell CB, Eriksson S. The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 1963;15:132-140.
2. Lieberman J. Heterozygous and homozygous alpha-1 antitrypsin deficiency in patients with pulmonary emphysema. N Engl J Med 1969;281:279-284.
3. Kueppers F, Fallat R, Larson RK. Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity. Science 1969;165:899-901.
4. Hersh CP, Dahl M, Ly NP, Berkey CS, Nordestgaard BG, Silverman EK. Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis. Thorax 2004;59:843-849.
5. Smolonska J, Wijmenga C, Postma DS, Boezen HM. Meta-analyses on suspected chronic obstructive pulmonary disease genes: a summary of 20 years' research. Am J Respir Crit Care Med 2009;180:618-631.
6. Castaldi PJ, Cho MH, Cohn M, Langerman F, Moran S, Tarragona N, Moukhachen H, Venugopal R, Hasimja D, Kao E, et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum Mol Genet 2010;19:526-534.
7. Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, et al. α1-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts. Chest 2010;138:1125-1132.
8. Molloy K, Hersh CP, Morris VB, Carroll TP, O'Connor CA, Lasky-Su JA, Greene CM, O'Neill SJ, Silverman EK, McElvaney NG. Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes. Am J Respir Crit Care Med 2014;189:419-427.
9. Foreman MG, Demeo D, Hersh C, Klanderman B, Ziniti J, Murphy J, Hokanson JE, Beaty T, Crapo J, Silverman EK. Alpha-1 Antitrypsin PI MZ heterozygosity is associated with COPD and CT emphysema in the COPDGene Study. Am J Respir Crit Care Med 2011;183:A5352.
10. Ortega VE, Pasha S, Ampleford EJ, Dimitrov L, Almonte C, Barr RG, Couper D, Han MK, Hoffman EA, Kanner RE, et al. Rare SERPINA1 variants are associated with lung function and emphysema in non-Hispanic whites from SPIROMICS. Am J Respir Crit Care Med 2015;191:A3656.
11. Hardin M, Silverman EK. Chronic obstructive pulmonary disease genetics: a review of the past and a look into the future. J COPD Foundation 2014;1:33-46.
12. Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, et al.; ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. Plos Genet 2009;5:e1000421.
13. Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, Myers RH, Borecki IB, Silverman EK, Weiss ST, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. Plos Genet 2009;5:e1000429.
14. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, DeMeo DL, Hunninghake GM, Litonjua AA, Sparrow D, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet 2010;42:200-202.
15. Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, DeMeo DL, Sylvia JS, Ziniti J, Laird NM, et al.; NETT Genetics, ICGN, ECLIPSE and COPDGene Investigators. Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. Lancet Respir Med 2014;2:214-225.
16. Repapi E, Sayers I, Wain LV, Burton PR, Johnson T, Obeidat M, Zhao JH, Ramasamy A, Zhai G, Vitart V, et al.; Wellcome Trust Case Control Consortium; NSHD Respiratory Study Team. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2010;42:36-44.
17. Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, Franceschini N, Van Durme YM, Chen TH, Barr RG, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2010;42:45-52.
18. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, et al.; International Lung Cancer Consortium; GIANT consortium. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 2011;43:1082-1090.
19. Cho MH, Castaldi PJ, Hersh CP, Hobbs BD, Barr RG, Tal-Singer R, Bakke P, Gulsvik A, San José Estépar R, Van Beek EJ, et al.; NETT Genetics, ECLIPSE, and COPDGene Investigators. A genome-wide association study of emphysema and airway quantitative imaging phenotypes. Am J Respir Crit Care Med 2015;192:559-569.
20. Castaldi PJ, Cho MH, San José Estépar R, McDonald ML, Laird N, Beaty TH, Washko G, Crapo JD, Silverman EK; COPDGene Investigators. Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. Am J Respir Crit Care Med 2014;190:399-409.
21. Lynch DA, Austin JH, Hogg JC, Grenier PA, Kauczor HU, Bankier AA, Barr RG, Colby TV, Galvin JR, Gevenois PA, et al. CT-definable subtypes of chronic obstructive pulmonary disease: a statement of the Fleischner Society. Radiology 2015;277:192-205.
22. Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, et al.; COPDGene and ECLIPSE Investigators. Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med 2014;14:164.
23. Castaldi PJ, Dy J, Ross J, Chang Y, Washko GR, Curran-Everett D, Williams A, Lynch DA, Make BJ, Crapo JD, et al. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax 2014;69:415-422.
24. Mehta AJ, Thun GA, Imboden M, Ferrarotti I, Keidel D, Künzli N, Kromhout H, Miedinger D, Phuleria H, Rochat T, et al.; SAPALDIA team. Interactions between SERPINA1 PiMZ genotype, occupational exposure and lung function decline. Occup Environ Med 2014;71:234-240.
25. DeMeo DL, Sandhaus RA, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard S, Burchard E, Stocks JM, Stoller JK, et al. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency. Thorax 2007;62:806-813.
26. Donato LJ, Karras RM, Katzmann JA, Murray DL, Snyder MR. Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles. Respir Res 2015;16:96.
27. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA. Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;166:377-386.
28. Silverman EK, Sandhaus RA. Clinical practice: alpha1-antitrypsin deficiency. N Engl J Med 2009;360:2749-2757.
29. ∗MZ heterozygotes: a cautionary note. Chest 2008;134:831-834.